| __timestamp | Exelixis, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2043000 | 2395000 |
| Thursday, January 1, 2015 | 3895000 | 9057000 |
| Friday, January 1, 2016 | 6552000 | 393000 |
| Sunday, January 1, 2017 | 15066000 | 79309000 |
| Monday, January 1, 2018 | 26348000 | 134428000 |
| Tuesday, January 1, 2019 | 33097000 | 175431000 |
| Wednesday, January 1, 2020 | 36272000 | 124165000 |
| Friday, January 1, 2021 | 52873000 | 121875000 |
| Saturday, January 1, 2022 | 57909000 | 10114000 |
| Sunday, January 1, 2023 | 72547000 | 9206000 |
| Monday, January 1, 2024 | 0 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. From 2014 to 2023, Exelixis, Inc. and Wave Life Sciences Ltd. have showcased intriguing cost trajectories. Exelixis, Inc. has seen a consistent rise in its cost of revenue, peaking at approximately $72.5 million in 2023, marking a staggering 3,450% increase from 2014. Meanwhile, Wave Life Sciences Ltd. experienced a more volatile journey, with costs surging to $175.4 million in 2019 before dropping to around $9.2 million in 2023. This fluctuation highlights the dynamic nature of biotech investments and the strategic shifts companies undergo. As the industry continues to innovate, these insights offer a glimpse into the financial strategies that drive growth and sustainability.
Analyzing Cost of Revenue: Johnson & Johnson and Wave Life Sciences Ltd.
Analyzing Cost of Revenue: United Therapeutics Corporation and Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Exelixis, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Exelixis, Inc.
R&D Spending Showdown: Exelixis, Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Trends: Exelixis, Inc. vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Galapagos NV
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Wave Life Sciences Ltd.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Perrigo Company plc vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.
Cost of Revenue Comparison: Wave Life Sciences Ltd. vs MiMedx Group, Inc.